Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?

Impact on glucometric variables and quality of life of the advanced hybrid closed‐loop system in pediatric and adolescent type 1 diabetes

(2023) Alfonso Lendínez‐Jurado et al.   Journal of Diabetes

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

(2022) Alice L.J. Carr et al.   DIABETES

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users

(2022) Arcelia Arrieta et al.   DIABETES OBESITY & METABOLISM

Predictors of time in target glucose range in real‐world users of the MiniMed 780G system

(2022) Javier Castañeda et al.   DIABETES OBESITY & METABOLISM

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

(2022) Ernesto Maddaloni et al.   DIABETES OBESITY & METABOLISM

Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain

(2022) Isabel Leiva-Gea et al.   Journal of Clinical Medicine

Insulin Requirements for Basal and Auto-Correction Insulin Delivery in Advanced Hybrid Closed-Loop System: 4193 Days’ Real-World Data of Children in Two Different Age Groups

(2022) Kağan Ege Karakuş et al.   Journal of diabetes science and technology

Long‐term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes

(2022) Barbara Piccini et al.   PEDIATRIC DIABETES

2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023

(2022) Nuha A. ElSayed et al.   DIABETES CARE

Real world use of hybrid‐closed loop in children and young people with type 1 diabetes mellitus—a National Health Service pilot initiative in England

(2022) Sze May Ng et al.   DIABETIC MEDICINE

ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents

(2022) Ingrid Libman et al.   PEDIATRIC DIABETES

Real-world outcomes with different technology modalities in type 1 diabetes

(2021) Pilar Isabel Beato-Víbora et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users

(2021) Julien Da Silva et al.   Diabetes Technology & Therapeutics

Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus

(2021) Gianluca Tornese et al.   Frontiers in Endocrinology

Age of onset of diabetes and all-cause mortality

(2020) Gary Yee Ang   World Journal of Diabetes

Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms

(2020) Bruno Vergès   DIABETES & METABOLISM

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

(2018) Monika Reddy et al.   Diabetes Technology & Therapeutics

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

(2018) Araz Rawshani et al.   LANCET

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

(2017) Aidin Rawshani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA 1c , and Insulin Dose

(2016) Wei Hao et al.   DIABETES CARE

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

(2016) Tatyana Mollayeva et al.   SLEEP MEDICINE REVIEWS

Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes

(2011) Kristen J. Nadeau et al.   Current Diabetes Reports